GOODWILL E-HEALTH INFO CO., LTD. Goodwill E-Health Info Co., Ltd. Stock
Equities
688246
CNE1000055V0
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.72 CNY | -1.32% |
|
+0.79% | -35.01% |
| Sales 2023 | 703M 97.06M | Sales 2024 * | 1.13B 155M | Capitalization | 3.01B 415M |
|---|---|---|---|---|---|
| Net income 2023 | 45M 6.21M | Net income 2024 * | 141M 19.46M | EV / Sales 2023 | 6.58 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 2.67 x |
| P/E ratio 2023 |
101
x | P/E ratio 2024 * |
20.6
x | Employees | 1,965 |
| Yield 2023 * |
1.06% | Yield 2024 * |
1.38% | Free-Float | 49.47% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.32% | ||
| 1 week | +0.79% | ||
| Current month | -21.19% | ||
| 1 month | -26.89% | ||
| 3 months | -15.29% | ||
| 6 months | -21.59% | ||
| Current year | -35.01% |
1 week
19.26
22.58
1 month
19.2630.17
Current year
17.1034.21
1 year
17.1045.60
3 years
17.1053.88
5 years
17.1053.88
10 years
17.1053.88
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Ren
FOU | Founder | 54 | 06-03-02 |
Jun Xia
CEO | Chief Executive Officer | 56 | 06-03-02 |
Lian Zhong Chen
CTO | Chief Tech/Sci/R&D Officer | 49 | 19-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jun Xia
CEO | Chief Executive Officer | 56 | 06-03-02 |
Xiang Xin Shi
BRD | Director/Board Member | 68 | 19-06-30 |
Ting Cai
CHM | Chairman | 51 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 21.72 | -1.32% | 2 227 811 |
| 24-04-24 | 22.01 | +5.26% | 2,472,870 |
| 24-04-23 | 20.91 | -0.71% | 1,849,913 |
| 24-04-22 | 21.06 | +4.72% | 2,231,651 |
| 24-04-19 | 20.11 | -3.36% | 2,118,642 |
End-of-day quote Shanghai S.E., April 24, 2024
More quotes
Goodwill E-Health Info Co Ltd is a China-based company mainly engaged in medical information business. The Company's main businesses are the development and sales of medical information software, software technical services, the production and sales of purchased software and hardware, and medical equipment. The Company's products include electronic medical record platforms, clinical pathway systems, mobile healthcare systems, digital medical record filing systems and other software-as-a-service (SaaS) products. The Company's products are mainly used in clinical medicine, hospital management, medical research, doctor-patient interaction, medical care integration, medical payment optimization and other fields.
Calendar
2024-04-26
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
22.01
CNY
Average target price
40
CNY
Spread / Average Target
+81.74%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -35.01% | 421M | |
| +2.37% | 32.41B | |
| +12.62% | 7.31B | |
| +20.05% | 3.85B | |
| -14.17% | 3.33B | |
| -28.57% | 1.26B | |
| -34.43% | 1.12B | |
| +1.35% | 932M | |
| -26.60% | 864M | |
| -38.17% | 863M |
- Stock Market
- Equities
- 688246 Stock
